Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.32 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.32 |
| ▸ | APP | P05067 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | NT5E | P21589 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA6 | P23280 | 1/20 | 0.32 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28518010 | 0.75 | — | — | |
| SCHEMBL6277591 | 0.73 | — | — | |
| SCHEMBL3628671 | 0.73 | — | — | |
| SCHEMBL28600525 | 0.73 | — | — | |
| SCHEMBL27604246 | 0.73 | — | — | |
| SCHEMBL360350 | 0.73 | — | — | |
| SCHEMBL1487192 | 0.72 | LMNA (0.43) | LMNASLC6A6CYP2C19BLMAPP | |
| SCHEMBL294039 | 0.71 | — | — | |
| Ethylene SCHEMBL8854273 | 0.71 | SLC22A6 (0.40) | SLC22A6LMNASLC6A6CYP2C19BLM | |
| SCHEMBL6772028 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10577530-B2 | Compounds and method for enhanced oil recovery using sulfur surfactants | INGEVITY SOUTH CAROLINA, LLC (US) | 2020-03-03 | — | — | US | disclosed |
| US-20190330515-A1 | COMPOUNDS AND METHOD FOR ENHANCED OIL RECOVERY USING SULFUR SURFACTANTS | MAINSTREAM PINE PRODUCTS, LLC | 2019-10-31 | — | — | US | disclosed |
| US-10435619-B1 | Compounds and method for enhanced oil recovery using sulfur surfactants | INGEVITY SOUTH CAROLINA, LLC (US) | 2019-10-08 | — | — | US | disclosed |
| US-10370582-B2 | Compounds and method for enhanced oil recovery using sulfur surfactants | INGEVITY SOUTH CAROLINA, LLC (US) | 2019-08-06 | — | — | US | disclosed |
| US-20160024373-A1 | COMPOUNDS AND METHOD FOR ENHANCED OIL RECOVERY USING SULFUR SURFACTANTS | INGEVITY SOUTH CAROLINA, LLC (US) | 2016-01-28 | — | — | US | disclosed |
| US-6617390-B2 | Catalytic polymerization of acrylic acid-acrylonitrile block copolymer; improved hydrophobic/hydrophilic distribution; thermal stability | REPLICATION MEDICAL, INC. | 2003-09-09 | — | — | US | disclosed |
| US-20020193531-A1 | Method of making synthetic hydrophilic polymers and products resulting therefrom | REPLICATION MEDICAL, INC. | 2002-12-19 | — | — | US | disclosed |
| US-6451922-B2 | TWO STAGE CATALYTIC REACTION OF POLYACRYLONITRILE IN PRESENCE AND ABSENCE OF SOLVENT TO FORM MULTIBLOCK POLYMER OF ACRYLIC ACID SALT, ACRYLAMIDE AND ACRYLIC ACID DERIVATIVE; MECHANICAL AND THERMAL STABILITY; COSMETICS; THICKENER; EMULSIFIER | REPLICATION MEDICAL, INC. | 2002-09-17 | — | — | US | disclosed |
| US-20010044502-A1 | Method of making synthetic hydrophilic polymers and products resulting therefrom | REPLICATION MEDICAL, INC. | 2001-11-22 | — | — | US | disclosed |
| EP-0910351-A1 | PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS | G.D. Searle & Co. (US) | 1999-04-28 | — | — | EP | disclosed |
| WO-1997049387-A1 | PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS | G.D. SEARLE AND CO. (US) | 1997-12-31 | — | — | WO | disclosed |
| US-5663273-A | APPLYING TO IMPART OIL AND WATER REPELLENCY | CIBA-GEIGY CORPORATION (US) | 1997-09-02 | — | — | US | disclosed |
| US-5525732-A | MONO- OR DI-SULFATE SUBSTITUTED ALCOHOLS OR POLYOLS AS INTERMEDIATES FOR WATER OR OIL REPELLENT TREATMENTS FOR TEXTILES OR PAPER SIZINGS | CIBA-GEIGY CORPORATION (US) | 1996-06-11 | — | — | US | disclosed |
| US-5491261-A | INTERMEDIATES FOR POLYURETHANES, OIL AND WATER REPELLENT MATERIALS; PAPER SIZING | CIBA-GEIGY CORPORATION (US) | 1996-02-13 | — | — | US | disclosed |
| EP-0690039-A2 | Poly-perfluoroalkyl-substituted alcohols and acids, and derivatives thereof | CIBA-GEIGY AG (CH) | 1996-01-03 | — | — | EP | disclosed |
| US-5428155-A | PH controlled sulfomethylation of 1,4,7,10-tetraazacyclododecane; displacement with sodium cyanide; hydrolysis to symmetrical acetic acid side groups | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1995-06-27 | — | — | US | disclosed |
| US-4564371-A | SALT OF SULFONIC ACID BONDED TO POLYMER THROUGH IMIDE OR AMIDE GROUP | NIPPON ZEON CO LTD (JP) | 1986-01-14 | — | — | US | disclosed |
| US-4252542-A | A CROSSLINKED AMINOMETHYLENE SULFONIC ACID; FUEL ADDITIVE; JET FUELS | STANDARD OIL COMPANY (INDIANA) (US) | 1981-02-24 | — | — | US | disclosed |
| EP-0005063-A1 | Reaction products having anti-static activity, process for their production and compositions containing them | Standard Oil Company (US) | 1979-10-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10435619-B1 | Compounds and method for enhanced oil recovery using sulfur surfactants | SRMS, SGMS2, SGMS1 | SLC22A6 2138/4885LMNA 1823/4885SLC6A6 1260/4885 |
| US-10577530-B2 | Compounds and method for enhanced oil recovery using sulfur surfactants | SRMS, SGMS2, SGMS1 | SLC22A6 2138/4885LMNA 1823/4885SLC6A6 1260/4885 |
| US-20190330515-A1 | COMPOUNDS AND METHOD FOR ENHANCED OIL RECOVERY USING SULFUR SURFACTANTS | SRMS, SGMS2, SGMS1 | SLC22A6 2138/4885LMNA 1823/4885SLC6A6 1260/4885 |
| US-10370582-B2 | Compounds and method for enhanced oil recovery using sulfur surfactants | SRMS, SGMS2, SGMS1 | SLC22A6 2138/4885LMNA 1823/4885SLC6A6 1260/4885 |
| US-20160024373-A1 | COMPOUNDS AND METHOD FOR ENHANCED OIL RECOVERY USING SULFUR SURFACTANTS | SRMS, SGMS2, SGMS1 | SLC22A6 2138/4885LMNA 1823/4885SLC6A6 1260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.